标签归档：haspin

Haspin-IN-3

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Haspin-IN-3 

Haspin-IN-3 (compound 8l) 是一种有效的 haspin 抑制剂，IC50 为 14 nM。Haspin-IN-3 具有抗癌作用。

Haspin-IN-3

Haspin-IN-3 Chemical Structure

CAS No. : 2416569-95-2

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Haspin-IN-3 (compound 8l) is a potent haspin inhibitor with IC50 of 14 nM. Haspin-IN-3 has anticancer effects[1].

IC50 & Target

IC50: 14 nM (Haspin)[1]
分子量

278.26

Formula

C16H10N2O3
CAS 号

2416569-95-2
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Malikotsi A Qhobosheane, et al. Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors. Bioorg Med Chem. 2020 Jun 1;28(11):115468.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Haspin-IN-2

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Haspin-IN-2 

Haspin-IN-2 (compound 4) 是一种有效的选择性的 haspin 抑制剂，IC50 为 50 nM。Haspin-IN-1 还抑制 CLK1 和 DYRK1A，IC50 分别为 445 nM 和 917 nM。

Haspin-IN-2

Haspin-IN-2 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Haspin-IN-2 (compound 4) is a potent and selective haspin inhibitor with an IC50 of 50 nM. Haspin-IN-1 also inbibits CLK1 and DYRK1A with IC50s of 445 nM and 917 nM, respectively[1].

IC50 & Target[1]

CLK1

445 nM (IC50)

DYRK1A

917 nM (IC50)

Haspin Kinase

50 nM (IC50)

分子量

256.22

Formula

C12H8N4O3
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Wael Zeinyeh, et al. Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity. Eur J Med Chem. 2022 Jun 5;236:114369.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Haspin-IN-2

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Haspin-IN-2 

Haspin-IN-2 (compound 4) 是一种有效的选择性的 haspin 抑制剂，IC50 为 50 nM。Haspin-IN-1 还抑制 CLK1 和 DYRK1A，IC50 分别为 445 nM 和 917 nM。

Haspin-IN-2

Haspin-IN-2 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Haspin-IN-2 (compound 4) is a potent and selective haspin inhibitor with an IC50 of 50 nM. Haspin-IN-1 also inbibits CLK1 and DYRK1A with IC50s of 445 nM and 917 nM, respectively[1].

IC50 & Target[1]

CLK1

445 nM (IC50)

DYRK1A

917 nM (IC50)

Haspin Kinase

50 nM (IC50)

分子量

256.22

Formula

C12H8N4O3
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Wael Zeinyeh, et al. Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity. Eur J Med Chem. 2022 Jun 5;236:114369.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Haspin-IN-1

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Haspin-IN-1 

Haspin-IN-1 (compound 2a) 是一种 haspin 抑制剂，IC50 为 119 nM。Haspin-IN-1 还抑制 CLK1 和 DYRK1A，IC50 分别为 221 nM 和 916.3 nM。

Haspin-IN-1

Haspin-IN-1 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Haspin-IN-1 (compound 2a) is a haspin inhibitor with an IC50 of 119 nM. Haspin-IN-1 also inbibits CLK1 and DYRK1A with IC50s of 221 nM and 916.3 nM, respectively[1].

IC50 & Target[1]

CLK1

221 nM (IC50)

DYRK1A

916.3 nM (IC50)

Haspin Kinase

119 nM (IC50)

分子量

272.28

Formula

C12H8N4O2S
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Wael Zeinyeh, et al. Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity. Eur J Med Chem. 2022 Jun 5;236:114369.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Haspin-IN-1

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Haspin-IN-1 

Haspin-IN-1 (compound 2a) 是一种 haspin 抑制剂，IC50 为 119 nM。Haspin-IN-1 还抑制 CLK1 和 DYRK1A，IC50 分别为 221 nM 和 916.3 nM。

Haspin-IN-1

Haspin-IN-1 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Haspin-IN-1 (compound 2a) is a haspin inhibitor with an IC50 of 119 nM. Haspin-IN-1 also inbibits CLK1 and DYRK1A with IC50s of 221 nM and 916.3 nM, respectively[1].

IC50 & Target[1]

CLK1

221 nM (IC50)

DYRK1A

916.3 nM (IC50)

Haspin Kinase

119 nM (IC50)

分子量

272.28

Formula

C12H8N4O2S
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Wael Zeinyeh, et al. Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity. Eur J Med Chem. 2022 Jun 5;236:114369.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Haspin-IN-1

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Haspin-IN-1 

Haspin-IN-1 (compound 2a) 是一种 haspin 抑制剂，IC50 为 119 nM。Haspin-IN-1 还抑制 CLK1 和 DYRK1A，IC50 分别为 221 nM 和 916.3 nM。

Haspin-IN-1

Haspin-IN-1 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Haspin-IN-1 (compound 2a) is a haspin inhibitor with an IC50 of 119 nM. Haspin-IN-1 also inbibits CLK1 and DYRK1A with IC50s of 221 nM and 916.3 nM, respectively[1].

IC50 & Target[1]

CLK1

221 nM (IC50)

DYRK1A

916.3 nM (IC50)

Haspin Kinase

119 nM (IC50)

分子量

272.28

Formula

C12H8N4O2S
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Wael Zeinyeh, et al. Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity. Eur J Med Chem. 2022 Jun 5;236:114369.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务